Skip to main content
. Author manuscript; available in PMC: 2020 Aug 1.
Published in final edited form as: Clin Gastroenterol Hepatol. 2018 Dec 14;17(9):1886–1893.e5. doi: 10.1016/j.cgh.2018.12.005

Figure 2:

Figure 2:

Patient-level sensitivity corresponding to 10% screening-level false positive rate for T=6, 12, and 24 months prior to HCC diagnosis and at any time prior to HCC diagnosis (Ever) and the associated 95% bootstrap percentile intervals.